After the EU General Court upholds a decision of the Board of Appeal to refuse registration of the mark CANNABIS STORE AMSTERDAM on the grounds of being contrary to accepted principles of morality, partner Claire Lehr looks at the details behind the decision.
This article first appeared on WTR Daily, part of World Trademark Review, in January 2020. For further information, please go to www.worldtrademarkreview.com.
Partner Heather McCann will be a guest speaker at the London NatWest Business Entrepreneur Accelerator Hub on 19 February talking about how to “PowerUp your IP”.
EIP today announces the appointment of partner Colin Lobban from an in-house role at Dyson.
Colin has 20 years of experience in IP both in senior roles at Dyson and in private practice at two IP firms in London. Colin will be based at the EIP office in Bath.
During his 12 years at Dyson Colin led the IP teams responsible for the vacuum cleaner and brushless motor divisions, and then later the automotive and battery programmes.
He was responsible for developing and executing Dyson’s IP strategy, managed all patent drafting and prosecution and freedom-to-operate activities in all areas, with a particular focus on powertrain, HVAC, and power electronics.
Colin Lobban, partner at EIP, said:
“I am thrilled to be joining such a progressive and thriving firm with a genuinely nice, and clearly very talented, group of people. I look forward to contributing to EIP’s continued growth and hope that my past experience will prove valuable in maintaining EIP’s tradition of providing clear and pragmatic IP advice to its growing number of clients.”
Matt Lawman, partner and head of the Bath office at EIP, said:
“I am delighted that Colin chose to join us at EIP. He brings with him a tremendous amount of in-house and commercial experience, which reinforces our approach and client offering. Colin will be an asset to our fast-growing engineering practice, and I look forward to him becoming an integral part of the team here in Bath.”
EIP has been highlighted as one of the world’s leading trademark specialists in the 2020 edition of the WTR 1000.
Researchers for the WTR 1000, published annually by World Trademark Review, highlighted EIP’s “reputation for fine trademark strategy and prosecution”. Partner and head of EIP Brands, Claire Lehr and partner, Paula Flutter, both received excellent feedback.
A client said Claire is “responsive, knowledgeable and switched-on, she provides practical and legally sound solutions, and always has clients’ best interests at heart.”
Paula Flutter “applies her expertise on a global scale, with excellent results.”
EIP today announces the appointment of partner Gareth Probert from HGF where he was head of the firm’s Nottingham office.
Gareth has spent more than 20 years in the IP profession with 10 years in senior roles including partner and head of the medtech group at Potter Clarkson. Gareth joined EIP on 3 February and is based in the London office where he will play a key role in developing the life sciences practice.
Gareth is highly skilled in contentious IP having represented clients in more than 250 Opposition and Appeal hearings at the European Patent Office. He has a track record of success in high-value difficult cases, including in several oppositions which were carried out in conjunction with parallel litigation proceedings.
He has achieved success in commercially significant opposition cases for clients including AstraZeneca, Novo Nordisk and Edwards Lifesciences. Within the medtech and healthcare industry Gareth has substantial experience in the FMCG, formulation, peptide, food and chemical sectors.
Gareth Probert, partner at EIP, said:
“I am excited to be joining EIP at such a significant milestone in the firm’s history as it approaches its 20th anniversary. EIP’s combined patent and litigation offering has long been a point of difference and I believe provides an attractive proposition for many companies in the medtech and life sciences sectors. I’m looking forward to helping shape the future development of EIP in these areas.”
Heather McCann, partner at EIP, said:
“Gareth has an impressive track record and expertise in the life sciences sector, having advised and represented a number of significant pharma companies, in particular with regards to their opposition and appeal strategies before the EPO. This is an exciting new development for EIP and I am thrilled he has decided to join us. Gareth will be at the forefront of our growth in this area.”